Results 211 to 220 of about 1,917,601 (292)

Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE). [PDF]

J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA.   +6 more
europepmc   +1 more source

Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 264-266, March 2025.
Kirsten E. Stewart, Chris RuiWen Kuo, Rory Chan, Brian J. Lipworth   +3 more
wiley   +1 more source

The Role of Innate Lymphoid Cells in Autoimmune, Allergic and Infectious Diseases: A Systematic Review

Immunology, EarlyView.
This systematic review establishes disease‐specific dysregulations of human innate lymphoid cells (ILCs), demonstrating that an ILC1/ILC3 imbalance compromises mucosal barriers in inflammatory bowel disease, while activated ILC2s drive allergic airway inflammation.
Luan F. Lückmann, Henrique R. Dal‐Pizzol, Louise M. Lückmann, Davi E. Salini, Bruna C. Hasckel, Mikaeli Minati, Bruno Kluwe‐Schiavon, Tatiana Barichello   +7 more
wiley   +1 more source

Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study. [PDF]

Biomedicines
Bonato M, Favero E, Savoia F, Drigo M, Rizzato S, Orzes E, Senna G, Romagnoli M.   +7 more
europepmc   +1 more source

Wiskott–Aldrich Syndrome Protein Is Required for Glucocorticoid‐Dependent Eosinopoiesis and Eosinophil‐Rich Inflammation in Murine Models

Immunology, EarlyView.
WASP links GC‐dependent bone marrow eosinopoiesis to eosinophil‐rich allergic lung inflammation. GC‐responsive WASP+ stromal niche drives eosinopoiesis, generating eosinophilic lung inflammation and airway hyperresponsiveness. In WASP‐deficient allergic asthma, GC production and airway hyperresponsiveness are preserved, but GC‐driven bone marrow ...
Bruno Marques Vieira, Lucas Everton Simões, Pedro Xavier‐Elsas, Maria Ignez Capella Gaspar‐Elsas   +3 more
wiley   +1 more source

Benralizumab in severe eosinophilic asthma

Signa Vitae
openaire   +1 more source

Cardiovascular Outcomes With Dupilumab Versus Omalizumab in Severe Asthma

Clinical &Experimental Allergy, EarlyView.
Po‐Cheng Shih, Chun‐Ting Lin, James Cheng Chung Wei   +2 more
wiley   +1 more source

Management of chronic urticaria: Current status and future prospect

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Chronic urticaria is driven by mast cell activation through autoimmune, inflammatory, and neuroimmune pathways. A structured approach combining diagnosis, patient‐reported outcomes, stepwise therapy, treatment optimization, monitoring and emerging targeted agents may improve disease control and enable more personalized management.
Andaç Salman, Mona Al‐Ahmad, Maryam Al‐Nesf, Chia‐Yu Chu, Luis Felipe Ensina, Ana M. Gimenez‐Arnau, Margarida Gonçalo, Clive Grattan, Michihiro Hide, Pavel Kolkhir, Martin Metz, Iman Nasr, Romi Saini, Simon Francis Thomsen, Torsten Zuberbier, Emek Kocaturk   +15 more
wiley   +1 more source

Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a <i>post hoc</i> analysis of the ANANKE study. [PDF]

ERJ Open Res
Senna G, Brussino L, Aliani M, Altieri E, Bracciale P, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, De Michele F, Del Giacco S, Di Marco F, Malerba L, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, D'Amato M, Caminati M.   +22 more
europepmc   +1 more source

Efficacy of Dupilumab in Patients From China With Persistent Type 2 Asthma With and Without an Allergic Phenotype

Clinical &Experimental Allergy, EarlyView.
Qingling Zhang, Zhenan Deng, Xiuhua Fu, Haohui Fang, Jie Lin, Jérôme Msihid, Yvonne Huang, Jason H. Kwah, Olivier Ledanois, Nanshan Zhong   +9 more
wiley   +1 more source